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Estimation of creatinine clearance requires knowledge of
creatinine generation which can vary in different groups of
patients. Since the main source of creatinine is muscle we
used dual-energy X-ray absorptiometry to measure the mass
of muscle in a cohort of adult men and women in Rochester,
Minnesota. Serum and 24 h urinary creatinines were
measured directly. The urinary creatinine was estimated
using equations based on age and gender and muscle mass
in order to calculate creatinine clearance. Among 664
subjects with a mean age of 55±20 years, 51% of whom
were women, the model fit for urinary creatinine estimated
with age and gender (R2¼ 0.359) was similar to that
estimated with measured muscle mass (R2¼ 0.359). The
likelihood of chronic kidney disease (creatinine clearance of
less than 60 ml/min per 1.73 m2) in older subjects was highest
with equations that used age, and likelihood of CKD in
women was highest with equations that used gender. The
outcomes of mortality and cardiovascular disease had
stronger associations with decreased creatinine clearance
calculated with age and gender than by the clearance
calculated with muscle mass. This could be explained by age
being a potent predictor of mortality and cardiovascular
disease independent of urinary creatinine, muscle mass, and
gender. Our study shows that the likelihood of chronic
kidney disease in the elderly and in women and the risk of
adverse outcomes may be inflated by equations that use
patient demographics to estimate creatinine generation.
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Chronic kidney disease (CKD) has been defined by a
glomerular filtration rate (GFR) or creatinine clearance
(CrCl) less than 60 ml/min per 1.73 m2, with no requirement
for corroborating evidence of kidney damage below this
threshold even if GFR is estimated rather than directly
measured.1 CrCl is calculated from the rate of creatinine
generation divided by the concentration of serum creatinine
(SCr). Intrinsic creatinine generation can be directly
measured with a 24-h collection of urinary creatinine
(UCr), but timing errors, incomplete collection, exercise,
diet, and stress lead to a substantial within-person varia-
bility.2–5 To address the imprecision and inconvenience of
directly measuring UCr, equations were developed to
estimate UCr using easily measured and precise surrogates.
The Cockcroft–Gault equation was developed to estimate
creatinine generation using age, sex, and weight.6 Later, the
Modification of Diet in Renal Disease (MDRD) equation was
developed to estimate creatinine generation using age, sex,
and race.7,8 Owing to the increased risk of mortality and
cardiovascular disease with CKD,9,10 automated reporting of
estimated CrCl (eCrCl) or GFR by these equations has been
advocated whenever SCr levels are evaluated.1,11
Relatively few studies have examined how the choice of
surrogates for creatinine generation influences associations
with CKD as classified with equations. Verhave et al.12 found
that the association with cardiovascular risk factors differed
between urinary CrCl, the Cockcroft–Gault equation, and the
MDRD equation. When comparing existing equations, it is
uncertain if differences are due to the surrogates for creatinine
generation vs other factors (estimating CrCl vs GFR, assay
calibration,13,14 or source population14–16). Demographic
variables are used in equations because they are convenient
and correlate with muscle mass, the primary source of
creatinine generation. However, this correlation is imperfect,
and the use of demographics may contribute to the poor
performance of equations for classifying CKD compared
with directly measured GFR.17 Further, demographics may
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associate with CKD, or with adverse outcomes of CKD,
independent of muscle mass or creatinine generation. This
study assessed whether equations based on age and sex lead to
bias in corresponding risk estimates compared with equations
based on a direct measure of muscle mass. The development
of novel estimating equations, using the same assays and the
same source population, ensured that differences in the
associations with each equation were fully explained by the
choice of surrogates for creatinine generation.
RESULTS
The study sample (n¼ 664) had a mean±s.d. age of 55±20
years; 51% were women. The mean±s.d. UCr was
1171±340 mg/1.73 m2 per day; Scr was 0.81±0.24 mg/
100 ml; muscle mass was 25±5 kg/1.73 m2; and dietary
protein was 77±23 g/day. There were four subjects missing
UCr levels and 19 subjects missing dietary protein measures.
Figure 1a shows UCr to be lower in women than in men and
lower with older age, particularly after 55 years. Figure 1b
shows that UCr is lower with decreased muscle mass, and
Figure 1c shows a lower UCr with decreased dietary protein
intake. Finally, Figure 1d confirms that, as expected, the
relation between muscle mass and demographics is similar to
that seen with UCr and demographics (Figure 1a).
Models were developed to estimate UCr with age, sex,
muscle mass, and dietary protein (Table 1). An age spline
transformation with a knot at 55 years led to a higher
model fit (R2) than linear age (0.174 vs 0.150, P¼ 0.03). A
model based on age and sex had a similar fit to one based on
muscle mass (0.359 vs 0.359, P¼ 0.86), but a model based on
muscle mass and age had a higher fit than a model based on
age and sex (0.424 vs 0.359, P¼ 0.0005). Sex was not a
significant independent predictor (P¼ 0.43) in a model with
age and muscle mass. Dietary protein was a significant
independent predictor (P¼ 0.002) in a model with muscle
mass and age, but this did not improve model fit on cross-
validation (Table 1). Models that estimate UCr, using
coefficients from the full sample, were converted into
R2 = 0.211 in men, R2 = 0.340 in women
R2 = 0.431 in men, R2 = 0.282 in women
R2 = 0.365
R2 = 0.182
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Figure 1 | Comparison between surrogates for creatinine generation rate. Estimation of 24-h urinary creatinine by age (a), dual-energy
X-ray absorptiometry skeletal muscle mass (b), and dietary protein (c) among an age-stratified sample of 660 Rochester, Minnesota
residents. (d) The relationship between muscle mass and age. Men—solid circles; women—open circles. Curves represent a smoother
regression (l¼ 100,000) for men (black) and women (gray) in (a) and (d), and linear regression in (b) and (c).
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equations for eCrCl by dividing by SCr (in mg/100 ml):
eCrClMuscle ¼exp½6:20 þ 0:033ðmuscle in kg=1:73m2Þ
=ðSCr14:4Þ
ð1Þ
eCrClAge; Sex ¼exp½7:26  0:26ðif femaleÞ
½0:011ðage-55Þif age455 years=ðSCr14:4Þ
ð2Þ
eCrClAge; Muscle ¼exp½6:37 þ 0:029ðmuscle in kg=1:73m2Þ
½0:0071ðage-55Þ if age455 years=ðSCr14:4Þ
ð3Þ
Table 2 compares measured urinary CrCl with eCrCl by
each equation. The mean CrCl varied slightly between
methods (103–105 ml/min per 1.73 m2) as expected with
logarithmic regression models. The interquartile range for
the difference between urinary CrCl and eCrCl was lowest
with eCrClAge,Muscle (22 ml/min per 1.73 m
2). The prevalence
of CKD was 8.9% with urinary CrCl, 3.3% with eCrClMuscle,
and 5.1% with eCrClAge,Sex. The increased likelihood of CKD
with age was higher with equations that used age than with
equations that did not use age. The likelihood of CKD in
women compared with men was lower with urinary CrCl and
eCrClAge,Muscle, but was not lower when muscle mass was
replaced by sex in the equation (eCrClAge,Sex). The increased
likelihood of CKD with decreasing muscle mass was higher in
the equations that used muscle mass, than in the equations
that did not use muscle mass.
The mean follow-up time to death or last clinic visit was
12.2 years. During follow-up, 26% (175/664) of the subjects
died, whereas the incidence of diagnosed cardiovascular
disease was 31% (162/525). This included coronary artery
disease in 19.4% (112/576), heart failure in 13.4% (86/643),
stroke in 12.7% (80/632), and peripheral arterial disease in
15.3% (93/607). Table 3 compares associations with out-
comes between each method of determining CrCl. With the
exception of heart failure, outcomes were more strongly
associated with eCrCl than urinary CrCl. There were stronger
associations between outcomes and eCrCl based on equations
that used age (eCrClAge,Sex and eCrClAge,Muscle) than with the
equation that did not use age (eCrClMuscle). This finding was
present irrespective of whether eCrCl was treated as a
continuous (per 30 ml/min per 1.73 m2) or a categorical
(o60, 60–89, 90 ml/min per 1.73 m2) variable.
As eCrCl equations differed only by the surrogates used to
estimate creatinine generation, differences in Table 3 were
further explored by assessing whether the surrogates
themselves were predictors of outcomes independent of their
correlation with creatinine generation. Table 4 compares the
risk (per s.d.) of each outcome with individual surrogates,
adjusting for all other surrogates for creatinine generation.
Age was a strong predictor of each outcome (hazard ratios
(HRs) 2.8–5.7; Po0.0001 for all) independent of UCr, muscle
mass, and sex. Decreased UCr was also an independent
Table 1 | Linear regression models estimating log (UCr/
1.73 m2) with surrogates for creatinine generation among an
age-stratified sample of 660 Rochester, Minnesota residents
Model variables Mean model R2
Age 0.150
Age splinea 0.174
Sex 0.190
Age spline, sexa 0.359b
Dietary protein 0.153
Muscle mass 0.359b
Muscle mass, dietary proteinc 0.358
Age spline, muscle massa 0.424b
Age spline, muscle massa, dietary proteinc 0.420
UCr, urinary creatinine.
The R2 is the mean from 10 replications of a random 10% (n=66) validation set using
coefficients estimated with the remaining 90% (n=594) training set.
aIf age p55 years, then age spline = 0; if age 455 years, then age spline = age –55
years.
bModels chosen for final equations.
cIn persons missing dietary protein (n=20), estimate based on similar model without
a dietary protein variable.
Table 2 | Comparison of creatinine clearance (CrCl) among an age-stratified sample of 664 Rochester, Minnesota residents
across methods used to measure or estimate the rate of creatinine generation
Urinary CrCl
Estimated CrCl
(muscle mass)
Estimated CrCl
(age and sex)
Estimated CrCl
(age and muscle mass)
Correlation, R Reference 0.71 0.71 0.75
Mean±s.d. 105±32 103±23 103±26 104±26
Interquartile range of estimated CrCl—urinary CrCl, ml/min per 1.73 m2 Reference 27 26 22
Prevalence of mild reduction, 60–89 ml/min per 1.73 m2 22% (n=148) 25% (n=164) 25% (n=163) 24% (n=158)
Prevalence of chronic kidney disease, o60 ml/min per 1.73 m2 8.9% (n=59) 3.3% (n=22) 5.1% (n=34) 5.7% (n=38)
Likelihood of chronic kidney disease with predictors that can also
be used as surrogates for low creatinine generation Odds ratio (95% confidence interval)
Age per s.d. (20 years) increase 3.6 (2.5, 5.5) 7.4 (3.4, 20) 13 (6.0, 36) 19 (8.2, 57)
Female vs male 0.5 (0.3, 0.8) 0.8 (0.3, 1.9) 0.9 (0.4, 1.7) 0.5 (0.2, 1.0)
Muscle mass per s.d. (5.3 kg/1.73 m2) decline 1.3 (1.0, 1.7) 2.0 (1.3, 3.5) 1.7 (1.1, 2.5) 1.8 (1.2, 2.6)
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predictor of mortality (HR¼ 1.6; P¼ 0.0009). Decreased
muscle mass was weakly associated with a lower risk of heart
failure (HR¼ 0.5; P¼ 0.02), and female sex was weakly
associated with lower mortality (HR¼ 0.5; P¼ 0.04)
independent of other surrogates. Results were similar with
further adjustment for dietary protein and SCr.
DISCUSSION
Two types of analyses are prominent in the literature on renal
function equations: the first focuses on the development and
validation of equations against directly measured GFR or
urinary CrCl, whereas the second focuses on epidemiological
associations with these equations. By combining these two
types of analyses, this study shows that the choice of
surrogates for creatinine generation in equations can
influence our understanding of risk factors for and outcomes
of CKD. In particular, we found that the use of age and sex
variables in equations that estimated creatinine clearance
distorted the likelihood of CKD by age and sex and
exaggerated the risk of mortality and cardiovascular disease
with CKD. This is important because a primary argument for
using equations over SCr alone to classify CKD has been that
equations correct for age and sex differences in muscle mass.
Unfortunately, the apparent likelihood of CKD is inflated in
women with equations that use sex and inflated in the elderly
with equations that use age. Equations that employ
demographics cannot uncouple the association of CKD with
age and sex from the estimation of creatinine generation with
age and sex. Further, the risk of mortality and cardiovascular
disease with CKD is inflated by equations that use age,
Table 3 | Risk of adverse outcomes with creatinine clearance (CrCl) among an age-stratified sample of 664 Rochester,
Minnesota residents across methods used to measure or estimate creatinine generation
Urinary CrCl eCrClMuscle eCrClAge,Sex eCrClAge,Muscle
Hazard ratios (95% confidence interval)
Adverse outcome per 30 ml/min per 1.73 m2 decline
Mortality 2.7 (2.3, 3.2) 2.9 (2.3, 3.5) 3.6 (2.9, 4.4) 3.5 (2.9, 4.2)
Cardiovascular disease 1.7 (1.4, 1.9) 1.8 (1.3, 2.4) 2.1 (1.7, 2.5) 2.1 (1.7, 2.5)
Coronary artery disease 1.4 (1.2, 1.7) 1.5 (1.1, 1.9) 1.8 (1.4, 2.3) 1.8 (1.4, 2.2)
Heart failure 2.3 (1.9, 2.9) 2.2 (1.6, 3.0) 3.1 (2.3, 4.0) 2.8 (2.2, 3.7)
Stroke 1.9 (1.5, 2.4) 2.1 (1.5, 2.8) 2.1 (1.6, 2.8) 2.2 (1.7, 3.0)
Peripheral vascular disease 1.7 (1.4, 2.1) 1.8 (1.3, 2.3) 2.0 (1.5, 2.5) 2.0 (1.6, 2.6)
60–89 vs X90 ml/min per 1.73 m2
Mortality 4.2 (3.0, 5.9) 3.3 (2.4, 4.6) 4.8 (3.4, 6.6) 4.0 (2.9, 5.6)
Cardiovascular disease 1.9 (1.3, 2.7) 2.0 (1.4, 2.8) 3.1 (2.2, 4.3) 3.1 (2.2, 4.3)
Coronary artery disease 1.5 (0.9, 2.3) 1.3 (0.8, 2.0) 1.9 (1.2, 2.9) 1.9 (1.3, 2.9)
Heart failure 3.4 (2.1, 5.5) 1.9 (1.2, 3.1) 4.2 (2.6, 6.7) 3.7 (2.3, 6.0)
Stroke 2.4 (1.4, 3.9) 2.6 (1.6, 4.1) 2.9 (1.8, 4.6) 2.9 (1.8, 4.7)
Peripheral vascular disease 2.0 (1.3, 3.2) 2.0 (1.3, 3.1) 3.0 (1.9, 4.6) 3.5 (2.3, 5.4)
o60 vs X90 ml/min per 1.73 m2
Mortality 8.8 (5.9, 13) 11 (6.4, 18) 16 (9.8, 25) 18 (11, 27)
Cardiovascular disease 3.1 (1.8, 5.0) 7.0 (3.3, 13) 8.1 (4.2, 14) 7.5 (3.8, 14)
Coronary artery disease 1.9 (0.9, 3.5) 4.2 (1.6, 8.8) 4.8 (2.2, 9.2) 4.8 (2.1, 9.4)
Heart failure 6.3 (3.4, 11) 11 (5.6, 21) 13 (6.8, 25) 15 (7.6, 27)
Stroke 3.9 (1.9, 7.4) 5.0 (1.5, 12) 7.6 (3.3, 16) 7.9 (3.4, 16)
Peripheral vascular disease 3.6 (1.9, 6.5) 4.7 (1.8, 10) 6.7 (3.0, 13) 9.3 (4.4, 18)
eCrCl, estimated creatinine clearance.
Table 4 | Adjusteda risk of adverse outcomes for surrogates of a decreasing rate of creatinine generation among an
age-stratified sample of 664 Rochester, Minnesota residents
Urinary creatinine per – s.d. Muscle mass per – s.d. Age per s.d. (20 years) Sex (female)
Adverse outcomes Hazard ratios (95% confidence interval)
Mortality 1.6 (1.2, 2.0) 0.9 (0.6, 1.3) 5.5 (4.1, 7.5) 0.5 (0.3, 1.0)
Cardiovascular disease 1.2 (1.0, 1.6) 0.7 (0.5, 1.0) 3.6 (2.8, 4.6) 1.1 (0.6, 2.2)
Coronary artery disease 0.9 (0.7, 1.2) 0.7 (0.4, 1.1) 3.5 (2.6, 4.8) 1.1 (0.5, 2.2)
Heart failure 1.4 (1.0, 2.0) 0.5 (0.3, 0.9) 5.7 (3.8, 8.6) 1.3 (0.5, 3.1)
Stroke 1.2 (0.8, 1.8) 1.1 (0.7, 2.0) 2.9 (2.1, 4.2) 0.8 (0.3, 2.1)
Peripheral vascular disease 1.2 (0.9, 1.6) 1.0 (0.6, 1.6) 2.8 (2.0, 3.9) 0.5 (0.2, 1.1)
aAdjusted for all other surrogates; results similar with further adjustment for dietary protein intake and reciprocal serum creatinine.
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because the residual variability in age that does not correlate
with creatinine generation is a strong predictor of these
outcomes.
In the first part of the analysis, muscle mass and dietary
protein were assessed as novel surrogates for creatinine
generation. Muscle mass was the individual surrogate with
the highest model fit for predicting UCr. This is not
surprising as creatinine, which is formed from creatine, is
the end product of muscle catabolism, and almost 98% of the
creatine pool is stored in muscle.18 The ‘creatinine equiva-
lence’ (kg muscle mass/g UCr) in this study was 21 kg/g,
consistent with a range of 17–22 kg/g reported in other
studies.5 Dietary protein,19 and cooked meat in particular,20
also increases UCr. In this study, dietary protein indepen-
dently predicted UCr but did not improve model fit on cross-
validation. However, dietary protein has an impact on
creatinine that varies with diet, and a 7-day diet history
may not capture the influence of dietary protein on
creatinine during a 24-h urine collection or at the moment
of a blood draw for SCr.
The comparison with directly measured muscle mass
provides a novel insight into the limitation of demographics
as surrogates for creatinine generation. Although it is well
known that the decline in muscle mass with age contributes
to the decline in UCr with age,5,21 age also predicts a decline
in UCr independent of muscle mass. The addition of age as
an equation variable with muscle mass improved the
prediction of UCr by 6.5% over muscle mass alone. A
potential explanation is that diffuse fat infiltration into
muscle, or ‘myosteatosis’ with aging,22 may not be fully
distinguishable from muscle itself by dual-energy X-ray
absorptiometry (DXA). On the other hand, as sex was not a
predictor of UCr independent of muscle mass, differences in
creatinine generation between the sexes could be fully
explained by differences in muscle mass.
How does an equation developed in the general popula-
tion compare with the MDRD and Cockcroft–Gault equa-
tions that were developed in select clinical populations? The
Cockcroft–Gualt equation was actually derived in a similar
manner to this study, by regressing UCr per kg body weight
onto age.6 Figure 2 shows that over the age of 40 years, UCr/
kg is higher in the general population than is estimated in
hospital medical wards with the Cockcroft–Gault equation. A
higher creatinine-generation rate in the general population
than CKD populations may also explain why GFR estimates
are higher in normal persons than in CKD patients at the
same SCr level.23 Direct comparison of eCrClAgeSex with the
MDRD equation is limited because UCr was not used to
derive the MDRD equation. As the MDRD equation was
derived using clinically diagnosed CKD patients, the demo-
graphic coefficients in that equation do not model risk of
CKD but rather primarily model creatinine generation. The
26% lower creatinine generation in women compared with
men with the MDRD equation is similar to the 23%
difference estimated by eCrClAgeSex. By using logarithmic
age to estimate creatinine generation, the MDRD equation
models the steepest decline with age in young adults, whereas
this study found that the steepest decline with age occurs in
older adults (Figure 1a). Douville et al.24 also found the
steepest decline with age in older adults.
In the second part of the analysis, the impact of using
demographics in equations on the epidemiology of CKD was
assessed by comparison with urinary CrCl and equations that
used muscle mass. The prevalence of CKD was highest with
urinary CrCl (8.9%), followed by eCrClAgeSex (5.1%), and the
lowest with eCrClMusc (3.3%). When comparing the pre-
valence of CKD between CrCl methods, it is important to
consider the within-person variability of the surrogates for
creatinine generation. The coefficient of variation for UCr is
relatively high at 15%,3 but trivial for DXA muscle mass at
0.6%25 and effectively 0% for demographics. The imprecision
of measured UCr compared with estimated UCr explains the
higher prevalence of CKD with urinary CrCl than with eCrCl.
The higher prevalence of CKD for equations that used age,
compared with equations that did not use age, was due to the
age-stratified study sample; because of the uniform age
distribution, the very elderly were over-represented compared
with other surrogates for low creatinine generation (that is,
there were equal numbers of subjects in the older and
middle-age groups, but fewer subjects with low muscle mass
compared with average muscle mass). The imprecision of
UCr and the limited twofold range of UCr in the general
population (10–90%: 779–1629 mg/1.73 m2) also lowers the
signal-to-noise ratio and limits the model fit (R2) for
estimating logarithmic UCr (Table 1).
When evaluating age as a risk factor for CKD, associations
were strongest with equations that used age as a surrogate for
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Figure 2 | Estimation of urinary creatinine per kg per day by
age among 660 Rochester, Minnesota residents in this study
(solid smoother curves) compared with that estimated by the
Cockcroft–Gault equation (dashed lines) in men (black) and
women (light gray).
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creatinine generation. The problem is that equations cannot
uncouple age as a surrogate for creatinine generation from
age as a risk factor for a low CrCl, and nothing is a stronger
predictor of age than age itself. Figure 3 shows that an
equation based on age and sex doubles the prevalence of
CKD in the elderly compared with an equation based on
muscle mass. This same problem is true for sex, because
equations cannot uncouple sex as a surrogate for creatinine
generation from sex as a risk factor for low CrCl, thus
inflating CKD in women. Unfortunately, this masks the
important finding that men actually have a higher likelihood
of CKD than women, as shown by urinary CrCl and an
equation that used muscle mass and age.
As expected, this study found that a reduced CrCl was a
strong predictor of mortality and cardiovascular disease. The
novel insight provided, however, is that these associations are
stronger with equations that include age than equations that
do not include age (Table 3). This was not explained by a
better estimation of creatinine generation with age, because
eCrClAge,Sex and eCrClMuscle, both had a similar R
2 of 0.36 for
estimating UCr. Instead, it was the residual variation in age
that does not correlate with creatinine generation that is a
potent predictor of adverse outcomes (Table 4). Female sex
was independently protective against mortality, consistent
with the increased longevity in women compared with men,
but this did not translate into substantive difference in
eCrClAge,Sex compared with eCrClAge,Musc with respect to
mortality risk. Interestingly, a decreased UCr was associated
with mortality independent of muscle mass, age, and sex. It is
possible that ‘cardiac cachexia’ or other illnesses with negative
creatinine balance could explain this finding.
There are several potential limitations to consider with
these findings. First, the equations in this study estimated
CrCl not GFR. The missing factor, tubular secretion of
creatinine (CrCl/GFR), is primarily affected by GFR26 and by
medications (for example, cimetidine and trimethoprim).
Nonetheless, these findings are still relevant because age, sex,
muscle mass and dietary protein are surrogates for creatinine
generation regardless of whether an equation estimates GFR
or CrCl. Rowe et al.27 found age to have no substantive
association with the tubular secretion of creatinine (CrCl/
GFR). Second, it might be argued that only the age–sex-
adjusted association between eCrCl and outcomes is worth
investigation. With age and sex adjustment, there is no
advantage to evaluating associations with eCrClage,sex over
evaluating these same associations with reciprocal SCr (1/
SCr), obviating the purpose for an equation. The impact of
using demographics in equations on CKD associations can
only be determined in analyses that do not adjust for
demographics. Finally, this study could not evaluate ethnicity
or race as a surrogate for creatinine generation because the
study population was almost exclusively non-Hispanic white.
By analogy, a black race variable used to model increased
creatinine generation (that is, the MDRD equation) would be
expected to underestimate CKD in blacks, and this hypoth-
esis is supported by other data.28
In conclusion, it has been widely reported that CKD is
common and under-recognized, particularly in the elderly
and women,29–31 but the use of demographics in equations
that classify CKD may be part of the problem. Bias from the
sex variable in the MDRD equation contributes to a higher
risk in women than men for estimated GFRo60 ml/min per
1.73 m2,32 contrary to the lower risk in women than men for
albuminuria,30 decline in estimated GFR over time,33 or end-
stage renal disease.34 To the extent adverse outcomes with
CKD are biased by equations that use age, targeted
interventions to treat CKD and prevent adverse outcomes
will be difficult to evaluate for efficacy. In the screening
setting, the evaluation of SCr levels with respect to the upper
limit of normal (1.3 mg/100 ml in men and 1.1 mg/100 ml in
women) may be a more defensible approach as these
thresholds also reflect an age-appropriate low GFR.35–38
Uncertainty regarding CKD with borderline SCr levels is
appropriate and may require further investigations (for
example, urinalysis, 24-h urinary protein and CrCl, and
renal ultrasound). Equations may be more appropriate for
staging disease severity after a clinical diagnosis of CKD has
been made.
MATERIALS AND METHODS
Setting and participants
As detailed elsewhere,25 an age- and sex-stratified random sample of
the Rochester, Minnesota population was identified using the
medical record linkage system of the Rochester Epidemiology
Project.39 After excluding dementia, death before contact, severe
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Figure 3 | The prevalence of chronic kidney disease (creatinine
clearance less than 60 ml/min per 1.73 m2) with 95%
confidence intervals across different age groups among 664
Rochester, Minnesota residents. The light gray column
represents estimated creatinine clearance with an equation based
on dual-energy X-ray absorptiometry skeletal muscle mass, and
the dark gray column represents estimated creatinine clearance
with an equation based on age and sex. In the elderly (age480
years), prevalence of CKD is 25% (95% CI: 17–34%) with an
equation based on age and sex compared with 13% (95% CI:
8.0–22%) with an equation based on muscle mass. CKD, chronic
kidney disease.
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debility, pregnancy, and radiation workers, 899 men and 812 women
were invited, of which 348 men (39%) and 351 women (43%)
participated in a study visit between 1991 and 1996. After excluding
subjects with missing DXA scans and SCr levels and restricting the
sample to non-Hispanic white ethnicity, there were 326 men and
338 women in the final sample. The sample was limited to non-
Hispanic whites, because race confounds the relationship between
SCr and GFR,7,15 and there was inadequate minority representation
to evaluate this factor. An institutional review board approved the
study, and the protocol was consistent with the principles of the
Declaration of Helsinki.
Measures of creatinine
Serum creatinine and UCr levels (from a home 24-h collection) were
determined with a rate-Jaffe assay (Multistat III plus; Instrumenta-
tion Laboratories, Lexington, MA, USA). SCr was calibrated to
standardized levels (SCrStandardized¼ 0.95 SCrStudy0.10), based
on the difference in mean SCr between this study and the third
National Health and Nutrition Examination Survey.13,40,41 Skeletal
muscle mass was measured with a whole-body DXA scan (Hologic
QDR 2000 instrument; Hologic, Waltham, MA, USA) using version
5.67 software. DXA exploits the attenuation of two photon energies
to determine the mass of mineral (that is, bone), fat, and lean (that
is, non-mineral, non-fat) in the body. Figure 4 shows the results of a
DXA scan, which is a two-dimensional (area-based) measure of
body composition as opposed to the three-dimensional (volume-
based) measures seen with computed tomography. The software
used skeletal landmarks to distinguish the extremities from the
trunk. Wang et al.42 found that lean mass in the extremities
represents 75% of the total body skeletal muscle mass. Thus, total
skeletal muscle mass (kg) was determined from the lean body mass
of all four extremities multiplied by 1.33. With repeated measures,
DXA lean body mass had a coefficient of variation of 0.6%.25
Dietary protein intake (g/day) was calculated by professional
dietitians from 7-day diet histories. Surrogates for creatinine
generation were measured on the day of the study visit (DXA scan)
or immediately before the study visit (24-h UCr and 7-day diet
history).
Outcomes
Diagnostic codes (manually or automatically coded from the final
diagnoses in clinical notes) since 1935 are indexed and linked among
nearly all local providers through the Rochester Epidemiology
Project.39 Outcomes were identified through March 2008 using
International Classification of Diseases-9 codes and equivalent
Hospital Adaptation of the International Classification of Diseases-8
codes. Coronary artery disease (410–413), heart failure (402.91,
428.0, 428.1, and 428.9), stroke (430, 431, 432.9, 433, 434, 435.0,
435.1, and 435.8), and peripheral arterial disease, including aortic
aneurism (440–444, 557.0, 557.1, 557.9, and 593.81), were evaluated
as individual outcomes and as a composite outcome of cardiovas-
cular disease. For estimating incident disease (after the study visit),
subjects with prevalent disease (before the study visit) were
excluded. Mortality was determined from Minnesota State death
certificates.
Statistical analysis
As the goal was to estimate CrCl in ml/min per 1.73 m2 of body
surface area, 24-h UCr was normalized to mg/1.73 m2 by multi-
plying by 1.73/body surface area. Body surface area was calculated
from height and weight with the DuBois equation.43 Muscle mass
was also normalized to kg per 1.73 m2. Logarithmic 24-h UCr was
regressed on each surrogate for creatinine generation (age, sex,
muscle mass, and dietary protein). A linear spline with a knot at 55
years was also considered for age. Multivariable linear regression
models with various combinations of age, sex, muscle mass, and
dietary protein were developed to estimate log UCr. Model fit (R2)
was determined in a random 10% (n¼ 66) validation set using
coefficients estimated with the remaining 90% (n¼ 594) training
set. This cross-validation was replicated for 10 different random
10%/90% splits, and the mean R2 was compared between models
with paired t-tests. CrCl (ml/min per 1.73 m2) was calculated by
dividing UCr (measured or estimated) by SCr 14.4
(min 100 ml)/(daysml). The prevalence of a mild reduction in
CrCl (60–89 ml/min per 1.73 m2) and of CKD (o60 ml/min per
1.73 m2)1 was compared between urinary and estimated CrCl.
Logistic regression compared the likelihood of CKD with
surrogates for decreasing creatinine generation: age, female sex,
and decreasing muscle mass across each method of estimating CrCl.
Cox proportional hazards models calculated the HR for morbidity
and mortality outcomes by each method of CrCl. Censoring
occurred for death (except when predicting mortality), last clinical
contact date, and March 2008. As CrCl equations differed only by
the choice of creatinine-generation surrogates, each surrogate was
evaluated as a predictor for outcomes independent of other
Figure 4 | Dual-energy X-ray absorptiometry scan of a 30-year-
old woman. Images generated from the scan can be optimized to
contrast skeleton (white) from soft tissue (black) as shown in the
left panel or to contrast lean mass (black) from fat (white) as
shown in the right panel.
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surrogates. All statistical analyses were performed with JMP, version
7.0.1 (SAS Institute Inc., Cary, NC, USA).
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